Global Western Blot Market (2021-2026)

Dublin, January 7, 2022 (GLOBE NEWSWIRE) – The “Western blotter market by product, (consumables (antibody), instrument (electrophoresis, blot system, imager (fluorescent))), application (biomedical, clinical diagnostics), end User (research institute, hospital, biopharma) – The Global Forecast to 2026 report “has been added to ResearchAndMarkets.com offer.

The global Western Blot market is expected to reach USD 1.4 billion by 2026, up from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.

Technological advancements, increasing public funding for biomedical research, increasing demand for personalized medicine, and increasing prevalence of HIV are the key factors driving the growth of the market.

By instrument segment, the Imagers sub-segment represented the fastest growing segment of the Western Blot market.

The instrument-based Western transfer market is segmented into gel electrophoresis instruments, transfer systems, and imagers. The growth of this product segment is mainly due to the automation of imagers, which simplifies the process of protein detection.

By end-user segment, the academic and research institute segment accounted for the largest share of the Western Blot market.

On the basis of end users, the Western Blot market is segmented into academic and research institutes, biopharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users. In 2020, academic and research institutes accounted for the largest share of the Western Blot market. The large share of the end-user segment of academic and research institutes can be attributed to increasing government investment in research activities and increasing research in the field of proteomics.

Asia-Pacific: The fastest growing region in the Western Blot market.

The Western Blot market in the Asia-Pacific region is expected to register the highest growth during the forecast period. The main factors driving the growth of the Asia-Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, the increased funding of life science research and growing initiatives related to the diagnosis of target diseases.

North America: Largest Western Blot Market Share

In 2020, North America accounted for the largest share of the Western Blot market. The major factors driving the growth of this regional market include the presence of major manufacturers of Western blotter products in this region, increased research funding, increased investment in proteomics research and the growing emphasis on personalized medicine.

Main topics covered:

1. Introduction

2 Research methodology

3 Executive summary

4 premium information
4.1 Western Blot Market Overview
4.2 Asia-Pacific: Western Blotter Market, by End User and Country (2020)
4.3 Western Blotting Instruments Market, by Type, 2020
4.4 Western Blotting Instruments Market for Blotting Systems, by Type, 2020
4.5 Western Blotting Instruments Market for Imagers, by Type, 2020

5 Market overview
5.1 Presentation
5.2 Market dynamics
5.2.1 Drivers
5.2.1.1 Technological advances
5.2.1.2 Increase public funding in the field of biomedical research
5.2.1.3 Growing demand for personalized medicine
5.2.1.4 Rising global prevalence and incidence of HIV / AIDS
5.2.2 Constraints
5.2.2.1 Emergence of alternative technologies
5.2.3 Opportunities
5.2.3.1 Emerging economies
5.2.4 Challenges
5.2.4.1 Requirement of high procedural efficiency for precise results
5.3 Impact of COVID-19 on the Western Blot Market
5.4 Patent analysis
5.4.1 Number of publications over the past 10 years
5.4.2 Top 10 holders of patents granted in the last 20 years
5.4.3 Top 10 players with the highest number of patent applications
5.4.4 List of recent patents
5.5 Regulatory guidance
5.5.1 North America
5.5.2 Europe
5.5.3 Emerging markets
5.6 Value chain analysis
5.7 Supply chain analysis
5.8 Porter’s five forces analysis
5.9 Ecosystem Analysis of Western Blot Market
5.9.1 Role in the ecosystem
5.10 Technology analysis
5.10.1 Alternatives to the traditional Western Blot
5.11 Ranges / scenarios
5.12 Business analysis
5.12.1 Business Analysis for Western Blot
5.13 Trends / disruptions affecting the client’s activities

6 Western Blotter Market, by Product
6.1 Presentation
6.2 Consumables
6.2.1 Reagents and buffers
6.2.1.1 High Consumption of Reagents and Buffers during Western Blot Process to Drive Market Growth
6.2.2 Antibodies and Conjugates
6.2.2.1 Primary antibodies
6.2.2.1.1 Primary antibodies are mainly used to recognize a specific protein of interest
6.2.2.2 Secondary antibodies
6.2.2.2.1 The high sensitivity of secondary antibodies facilitates the detection of proteins of interest in complex mixtures of proteins
6.2.2.3 Other antibodies and conjugates
6.2.3 Kits
6.2.3.1 Repeated Purchases of Disposable Ready-to-Use Kits to Drive Market Growth
6.2.4 Membranes and filter papers
6.2.4.1 Extensive use of membranes and filter papers to support immobilization and blot steps during Western blot experiments to drive market growth
6.2.5 Other consumables
6.3 Instruments
6.3.1 Gel electrophoresis instruments
6.3.1.1 Increased demand for 2D electrophoresis due to its high separation performance is one of the major growth factors of the market
6.3.2 Blotting systems
6.3.2.1 Wet transfer systems
6.3.2.1.1 Wet systems are most commonly used for the transfer of proteins from gels to membranes
6.3.2.2 Semi-dry blotting systems
6.3.2.2.1 The minimal use of buffers during the process and the rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry transfer systems
6.3.3 Imagers
6.3.3.1 Chemiluminescent imagers
6.3.3.1.1 The low cost of these imagers, easy handling and sensitivity are some of the key factors contributing to the large share of this market
6.3.3.2 Fluorescent imagers
6.3.3.2.1 Fluorescent imagers serve as one-stop-shop imaging systems as they avoid multiple film exposures and development steps
6.3.3.3 Other imagers

7 Western Blotter Market, By Application
7.1 Presentation
7.2 Biomedical research
7.2.1 Increase research funding for proteomics and protein-based research – a major driver for this application segment
7.3 Clinical diagnosis
7.3.1 HIV
7.3.1.1 Western Blot is the most widely used method for the diagnosis of HIV – a key factor in the growth of the market
7.3.2 Hepatitis
7.3.2.1 Growing Incidence of Hepatitis C to Drive Market Growth
7.3.3 Lyme disease
7.3.3.1 Western blots are generally considered to be the most reliable tests currently available for the diagnosis of Lyme disease
7.3.4 Other diseases
7.4 Agricultural applications
7.4.1 Growing Cultivation of Genetically Modified Crops to Drive Market Growth
7.5 Other applications

8 Western Blotter Market, By End User
8.1 Presentation
8.2 University and research institutes
8.2.1 Increase government investments for research activities to drive growth in this market segment
8.3 Biopharmaceutical and biotechnology companies
8.3.1 Growth in Drug Discovery and Clinical Studies to Drive Demand for Western Blot in Pharmaceutical and Biotech Industry
8.4 Hospitals and diagnostic laboratories
8.4.1 Increasing Patient Population and Testing Volumes to Drive Market Growth
8.5 Other end users

9 Western Blotter Market, by Region

10 Competitive landscape
10.1 Strategies of key players
10.2 Overview of Strategies Adopted by Major Western Blot Market Players
10.3 Market share analysis
10.4 Revenue analysis
10.5 Company valuation quadrant
10.5.1 Stars
10.5.2 Omnipresent actors
10.5.3 Emerging leaders
10.5.4 Participants
10.6 Mapping of competitive leadership (start-ups) (2020)
10.6.1 Progressive companies
10.6.2 Starting blocks
10.6.3 Dynamic businesses
10.6.4 Responsive companies
10.7 Competitive benchmarking
10.8 Competitive scenario
10.8.1 Product launches
10.8.2 Offers
10.8.3 Other developments

11 company profiles
11.1 Key companies
11.1.1 Bio-Rad Laboratories, Inc.
11.1.2 Thermo Fisher Scientific Inc.
11.1.3 Danaher Company
11.1.4 Bio-Techné Company
11.1.5 Merck KGaA
11.1.6 Perkinelmer, Inc.
11.1.7 Abcam plc
11.1.8 Enzo Biochem, Inc.
11.1.9 Li-Cor, Inc.
11.1.10 Advansta inc.
11.1.11 Cell Signaling Technology, Inc.
11.1.12 Azure Biosystems, Inc.
11.1.13 Boosting biological technology
11.1.14 Geno Technology inc.
11.1.15 Stressmarq Biosciences Inc.
11.2 Other companies
11.2.1 F. Hoffmann-La Roche Ltée.
11.2.2 Rockland Immunochemicals, Inc.
11.2.3 Precision biosystems
11.2.4 Cleaver Scientific Ltd.
11.2.5 Proteintech Group
11.2.6 Abnova Corporation
11.2.7 Sino Biologique Inc.
11.2.8 Abbexa Ltd.
11.2.9 Covalab SAS
11.2.10 Biorbyt SA

12 Annex

For more information on this report, visit https://www.researchandmarkets.com/r/3x9du

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Comment